Table 1: Lung Cancer – Pipeline Products by Stage of Development 21
Table 2: Lung Cancer – Pipeline Products by Territory 22
Table 3: Lung Cancer – Pipeline Products by Regulatory Path 23
Table 4: Lung Cancer – Pipeline Products by Estimated Approval Date 24
Table 5: Lung Cancer – Ongoing Clinical Trials 25
Table 6: Lung Cancer Companies – Pipeline Products by Stage of Development 26
Table 7: Lung Cancer – Pipeline Products by Stage of Development 31
Table 8: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 9: Onco 88 – Lung Cancer – Product Status 36
Table 10: Onco 88 – Lung Cancer – Product Description 36
Table 11: OncoStain 88 – Lung Cancer – Product Status 37
Table 12: OncoStain 88 – Lung Cancer – Product Description 37
Table 13: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 38
Table 14: Alinity i Assay – NSE – Product Status 38
Table 15: Alinity i Assay – NSE – Product Description 39
Table 16: ARCHITECT c4000 System – NSE Assay – Product Status 39
Table 17: ARCHITECT c4000 System – NSE Assay – Product Description 39
Table 18: ARCHITECT c8000 System – NSE Assay – Product Status 40
Table 19: ARCHITECT c8000 System – NSE Assay – Product Description 40
Table 20: ARCHITECT ci4100 Integrated System – NSE Assay – Product Status 40
Table 21: ARCHITECT ci4100 Integrated System – NSE Assay – Product Description 41
Table 22: ARCHITECT ci8200 Integrated System – NSE Assay – Product Status 41
Table 23: ARCHITECT ci8200 Integrated System – NSE Assay – Product Description 41
Table 24: ARCHITECT i1000SR System – NSE Assay – Product Status 42
Table 25: ARCHITECT i1000SR System – NSE Assay – Product Description 42
Table 26: ARCHITECT i2000SR System – Neuron-Specific Enolase Assay – Product Status 42
Table 27: ARCHITECT i2000SR System – Neuron-Specific Enolase Assay – Product Description 43
Table 28: PRAME Antigen Lung Cancer Assay – Product Status 43
Table 29: PRAME Antigen Lung Cancer Assay – Product Description 43
Table 30: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
Table 31: Diagnostic Assay – Lung Cancer – Product Status 44
Table 32: Diagnostic Assay – Lung Cancer – Product Description 44
Table 33: MCM Test – Lung Cancer – Product Status 45
Table 34: MCM Test – Lung Cancer – Product Description 45
Table 35: Aberystwyth University Pipeline Products & Ongoing Clinical Trials Overview 46
Table 36: Diagnostic Biomarker Test – Lung Cancer – Product Status 46
Table 37: Diagnostic Biomarker Test – Lung Cancer – Product Description 46
Table 38: Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview 47
Table 39: Diagnostic Test – ACTN4 – Product Status 47
Table 40: Diagnostic Test – ACTN4 – Product Description 47
Table 41: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 48
Table 42: Companion Diagnostic Test – Lung Cancer – Product Status 48
Table 43: Companion Diagnostic Test – Lung Cancer – Product Description 48
Table 44: Diagnostic/Prognostic Assay – Lung Cancer – Product Status 49
Table 45: Diagnostic/Prognostic Assay – Lung Cancer – Product Description 49
Table 46: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview 50
Table 47: DiagnoLung – Product Status 50
Table 48: DiagnoLung – Product Description 50
Table 49: Predictive Diagnostic Test – Lung Cancer – Product Status 51
Table 50: Predictive Diagnostic Test – Lung Cancer – Product Description 51
Table 51: Prognostic Test – Lung Cancer – Product Status 51
Table 52: Prognostic Test – Lung Cancer – Product Description 52
Table 53: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 53
Table 54: Biomarker Assay – Lung Cancer – Product Status 53
Table 55: Biomarker Assay – Lung Cancer – Product Description 53
Table 56: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
Table 57: Prognostic Test – Early Stage Lung Cancer – Product Status 54
Table 58: Prognostic Test – Early Stage Lung Cancer – Product Description 54
Table 59: Prognostic Test – NSCLC – Product Status 55
Table 60: Prognostic Test – NSCLC – Product Description 55
Table 61: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
Table 62: Cchek – Lung Cancer Confirmatory Test – Product Status 56
Table 63: Cchek – Lung Cancer Confirmatory Test – Product Description 56
Table 64: Cchek – Lung Cancer Recurrence Test – Product Status 57
Table 65: Cchek – Lung Cancer Recurrence Test – Product Description 57
Table 66: Cchek – Lung Cancer Screening Test – Product Status 57
Table 67: Cchek – Lung Cancer Screening Test – Product Description 58
Table 68: Cchek – Lung Cancer Treatment Monitoring Test – Product Status 58
Table 69: Cchek – Lung Cancer Treatment Monitoring Test – Product Description 58
Table 70: Anixa Diagnostics Corporation – Ongoing Clinical Trials Overview 59
Table 71: Cchek – Lung Cancer Screening Test – The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors 60
Table 72: Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 61
Table 73: Diagnostic Test – Lung Cancer – Product Status 61
Table 74: Diagnostic Test – Lung Cancer – Product Description 61
Table 75: Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
Table 76: Lung Cancer Screening Test – Product Status 62
Table 77: Lung Cancer Screening Test – Product Description 62
Table 78: Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 79: TheraLink Assay – Non-Small Cell Lung Cancer – Product Status 63
Table 80: TheraLink Assay – Non-Small Cell Lung Cancer – Product Description 63
Table 81: BARD1 Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 64
Table 82: BARD1 Lung Cancer Test – Product Status 64
Table 83: BARD1 Lung Cancer Test – Product Description 64
Table 84: BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
Table 85: CyPath Lung – Product Status 65
Table 86: CyPath Lung – Product Description 65
Table 87: BioAffinity Technologies, Inc. – Ongoing Clinical Trials Overview 66
Table 88: CyPath Lung – Collection of Sputum and Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung Cancer 67
Table 89: Biocept Inc Pipeline Products & Ongoing Clinical Trials Overview 68
Table 90: Companion Diagnostic Target Selector Test – SCLC – Product Status 68
Table 91: Companion Diagnostic Target Selector Test – SCLC – Product Description 69
Table 92: MicroRNA Test – Lung Cancer – Product Status 69
Table 93: MicroRNA Test – Lung Cancer – Product Description 69
Table 94: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 70
Table 95: Companion Diagnostic Test – NSCLC – Product Status 70
Table 96: Companion Diagnostic Test – NSCLC – Product Description 70
Table 97: TAm-Seq NGS Lung Cancer Test – Product Status 71
Table 98: TAm-Seq NGS Lung Cancer Test – Product Description 71
Table 99: Biological Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 72
Table 100: OncoState Lung Assay – Product Status 72
Table 101: OncoState Lung Assay – Product Description 72
Table 102: BioMark Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 73
Table 103: Metabolomics-based Diagnostic Assay – Lung Cancer – Product Status 73
Table 104: Metabolomics-based Diagnostic Assay – Lung Cancer – Product Description 73
Table 105: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview 74
Table 106: Ex Vivo Biomarker Test – Lung Cancer – Product Status 74
Table 107: Ex Vivo Biomarker Test – Lung Cancer – Product Description 74
Table 108: PathMAP NSCLC – Product Status 75
Table 109: PathMAP NSCLC – Product Description 75
Table 110: BioNTech SE Pipeline Products & Ongoing Clinical Trials Overview 76
Table 111: Lung Cancer Screening Test – Product Status 76
Table 112: Lung Cancer Screening Test – Product Description 76
Table 113: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 77
Table 114: Quantiplasma Lung Cancer ELISA Test – Product Status 77
Table 115: Quantiplasma Lung Cancer ELISA Test – Product Description 77
Table 116: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview 78
Table 117: Collagen XXIII Biomarker Assay – NSCLC – Product Status 78
Table 118: Collagen XXIII Biomarker Assay – NSCLC – Product Description 78
Table 119: Cancer Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 79
Table 120: Companion Diagnostic Test – Tavocept – Product Status 79
Table 121: Companion Diagnostic Test – Tavocept – Product Description 79
Table 122: Cancer Research Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
Table 123: MCM Test – Lung Cancer – Product Status 80
Table 124: MCM Test – Lung Cancer – Product Description 80
Table 125: Cangen Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 81
Table 126: Diagnostic Test – Early Stage Lung Cancer – Product Status 81
Table 127: Diagnostic Test – Early Stage Lung Cancer – Product Description 81
Table 128: CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 82
Table 129: Diagnostic Test – Lung Cancer – Product Status 82
Table 130: Diagnostic Test – Lung Cancer – Product Description 82
Table 131: Celcuity Inc Pipeline Products & Ongoing Clinical Trials Overview 83
Table 132: CELsignia Test – Lung Cancer – Product Status 83
Table 133: CELsignia Test – Lung Cancer – Product Description 83
Table 134: Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 84
Table 135: Cellanyx Test – Lung Cancer – Product Status 84
Table 136: Cellanyx Test – Lung Cancer – Product Description 84
Table 137: Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
Table 138: LungDx – Product Status 85
Table 139: LungDx – Product Description 85
Table 140: CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 86
Table 141: CellCorrect LAb Test For Lung Cancer – Product Status 86
Table 142: CellCorrect LAb Test For Lung Cancer – Product Description 86
Table 143: Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview 87
Table 144: Xpert Lung CA Early Detection Test – Product Status 87
Table 145: Xpert Lung CA Early Detection Test – Product Description 87
Table 146: Xpert OncoScreen Lung Cancer Assay – Product Status 88
Table 147: Xpert OncoScreen Lung Cancer Assay – Product Description 88
Table 148: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 89
Table 149: Nanotrap Lung Cancer Biomarker Test – Product Status 89
Table 150: Nanotrap Lung Cancer Biomarker Test – Product Description 89
Table 151: Cernostics Inc Pipeline Products & Ongoing Clinical Trials Overview 90
Table 152: TissueCypher Lung Cancer Test – Product Status 90
Table 153: TissueCypher Lung Cancer Test – Product Description 90
Table 154: ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview 91
Table 155: Prognostic Test – Lung Cancer – Product Status 91
Table 156: Prognostic Test – Lung Cancer – Product Description 91
Table 157: Clarient Inc Pipeline Products & Ongoing Clinical Trials Overview 92
Table 158: ALK PCR Test – NSCLC – Product Status 92
Table 159: ALK PCR Test – NSCLC – Product Description 92
Table 160: PulmoTax – Product Status 93
Table 161: PulmoTax – Product Description 93
Table 162: Courtagen Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 94
Table 163: Lung Cancer Diagnostic Panel – Product Status 94
Table 164: Lung Cancer Diagnostic Panel – Product Description 94
Table 165: Creatv MicroTech Inc Pipeline Products & Ongoing Clinical Trials Overview 95
Table 166: LifeTracDx Blood Test – Product Status 95
Table 167: LifeTracDx Blood Test – Product Description 95
Table 168: DiagnoCure Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 96
Table 169: Diagnostic Test – Lung Cancer – Product Status 96
Table 170: Diagnostic Test – Lung Cancer – Product Description 96
Table 171: EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview 97
Table 172: PulmoMarker Test – Product Status 97
Table 173: PulmoMarker Test – Product Description 97
Table 174: Emory University Pipeline Products & Ongoing Clinical Trials Overview 98
Table 175: Biomarker Assay – Small Cell Lung Cancer – Product Status 98
Table 176: Biomarker Assay – Small Cell Lung Cancer – Product Description 98
Table 177: Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview 99
Table 178: IOC520 – Product Status 99
Table 179: IOC520 – Product Description 99
Table 180: Entopsis LLC Pipeline Products & Ongoing Clinical Trials Overview 100
Table 181: OpsisDx Test – Lung Cancer – Product Status 100
Table 182: OpsisDx Test – Lung Cancer – Product Description 100
Table 183: Epic Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 101
Table 184: PD-L1 Blood Test – Product Status 101
Table 185: PD-L1 Blood Test – Product Description 101
Table 186: Epigenomics AG Pipeline Products & Ongoing Clinical Trials Overview 102
Table 187: Blood – Based Lung Cancer Test – Product Status 102
Table 188: Blood – Based Lung Cancer Test – Product Description 102
Table 189: Eventus Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 103
Table 190: Octava Test – Lung Cancer – Product Status 103
Table 191: Octava Test – Lung Cancer – Product Description 103
Table 192: Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview 104
Table 193: Blood-based Lung Cancer Screening Test – Product Status 104
Table 194: Blood-based Lung Cancer Screening Test – Product Description 104
Table 195: Exiqon AS Pipeline Products & Ongoing Clinical Trials Overview 105
Table 196: miRNA Test – Lung Cancer – Product Status 105
Table 197: miRNA Test – Lung Cancer – Product Description 105
Table 198: Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 106
Table 199: Midi Lung Cancer Panel – Product Status 106
Table 200: Midi Lung Cancer Panel – Product Description 106
Table 201: Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview 107
Table 202: ExoTEST Lung – Product Status 107
Table 203: ExoTEST Lung – Product Description 107
Table 204: Fahy Gurteen UK Ltd Pipeline Products & Ongoing Clinical Trials Overview 108
Table 205: Diagnostic Test – Lung Cancer – Product Status 108
Table 206: Diagnostic Test – Lung Cancer – Product Description 108
Table 207: FibroStatin SL Pipeline Products & Ongoing Clinical Trials Overview 109
Table 208: EMTEST – NSCLC – Product Status 109
Table 209: EMTEST – NSCLC – Product Description 109
Table 210: Fina Biotech SL Pipeline Products & Ongoing Clinical Trials Overview 110
Table 211: Dx Bioenergetic Signature – Lung Cancer – Product Status 110
Table 212: Dx Bioenergetic Signature – Lung Cancer – Product Description 110
Table 213: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 111
Table 214: Diagnostic Assay – NSCLC Aggression – Product Status 111
Table 215: Diagnostic Assay – NSCLC Aggression – Product Description 111
Table 216: Gene Express, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 112
Table 217: Lung Cancer Diagnostic Assay – Product Status 112
Table 218: Lung Cancer Diagnostic Assay – Product Description 112
Table 219: SCLC vs NSCLC Subclassification Diagnostic test – Product Status 113
Table 220: SCLC vs NSCLC Subclassification Diagnostic test – Product Description 113
Table 221: GeneCentric Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114
Table 222: Diagnostic Test – Non small Cell Lung Cancer – Product Status 114
Table 223: Diagnostic Test – Non small Cell Lung Cancer – Product Description 114
Table 224: Genome Profiling LLC Pipeline Products & Ongoing Clinical Trials Overview 115
Table 225: Immune System Blood Test – NSCLC – Product Status 115
Table 226: Immune System Blood Test – NSCLC – Product Description 115
Table 227: Global Discovery Biosciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 116
Table 228: Aptamer-Based Blood Test – Lung Cancer – Product Status 116
Table 229: Aptamer-Based Blood Test – Lung Cancer – Product Description 116
Table 230: GlycoZym USA Inc Pipeline Products & Ongoing Clinical Trials Overview 117
Table 231: Diagnostic Assay – Lung Cancer – Product Status 117
Table 232: Diagnostic Assay – Lung Cancer – Product Description 117
Table 233: Guardant Health Inc Pipeline Products & Ongoing Clinical Trials Overview 118
Table 234: Guardant360 CDx Test – Amivantamab – Product Status 118
Table 235: Guardant360 CDx Test – Amivantamab – Product Description 118
Table 236: Guardant360 CDx Test – Tepotinib – Product Status 119
Table 237: Guardant360 CDx Test – Tepotinib – Product Description 119
Table 238: GuardantOMNI Test – Imfinzi – Product Status 119
Table 239: GuardantOMNI Test – Imfinzi – Product Description 120
Table 240: ImmunePharma Srl Pipeline Products & Ongoing Clinical Trials Overview 121
Table 241: Diagnostic Blood Test – Lung Cancer – Product Status 121
Table 242: Diagnostic Blood Test – Lung Cancer – Product Description 121
Table 243: ImmunoCellular Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 122
Table 244: Diagnostic Test – SCLC – Product Status 122
Table 245: Diagnostic Test – SCLC – Product Description 122
Table 246: Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview 123
Table 247: IMMray – NSCLC – Product Status 123
Table 248: IMMray – NSCLC – Product Description 123
Table 249: Immunovia AB – Ongoing Clinical Trials Overview 124
Table 250: IMMray – NSCLC – Study to Evaluate the Performance of IMMray Platform in the Diagnosis of Lung Cancer 125
Table 251: Insight Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 126
Table 252: Insight ROS1 Fusion Screen Assay – Product Status 126
Table 253: Insight ROS1 Fusion Screen Assay – Product Description 126
Table 254: NGS Lung Panel Test – Product Status 127
Table 255: NGS Lung Panel Test – Product Description 127
Table 256: InterGenetics Inc Pipeline Products & Ongoing Clinical Trials Overview 128
Table 257: OncoVue Lung – Product Status 128
Table 258: OncoVue Lung – Product Description 128
Table 259: Louisville Bioscience Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 129
Table 260: Lung Cancer Remission pT Test – Product Status 129
Table 261: Lung Cancer Remission pT Test – Product Description 129
Table 262: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 130
Table 263: Blood Test – NSCLC – Product Status 130
Table 264: Blood Test – NSCLC – Product Description 130
Table 265: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 131
Table 266: Protein Biomarker Panel – Lung Cancer – Product Status 131
Table 267: Protein Biomarker Panel – Lung Cancer – Product Description 131
Table 268: MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 132
Table 269: Lung Mitomic Test – Product Status 132
Table 270: Lung Mitomic Test – Product Description 132
Table 271: MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview 133
Table 272: ConfirmMDx Lung Cancer Test – Product Status 133
Table 273: ConfirmMDx Lung Cancer Test – Product Description 133
Table 274: MEDITE Cancer Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 134
Table 275: Screening Assay – Lung Cancer – Product Status 134
Table 276: Screening Assay – Lung Cancer – Product Description 134
Table 277: Memory Dx LLC Pipeline Products & Ongoing Clinical Trials Overview 135
Table 278: LC Sentinel Test – Product Status 135
Table 279: LC Sentinel Test – Product Description 135
Table 280: Merrimack Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 136
Table 281: MM-121 Companion Diagnostic Assay – Cancer – Product Status 136
Table 282: MM-121 Companion Diagnostic Assay – Cancer – Product Description 136
Table 283: Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview 137
Table 284: Diagnostic Test – Lung Cancer – Product Status 137
Table 285: Diagnostic Test – Lung Cancer – Product Description 137
Table 286: Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 138
Table 287: Diagnostic Assay – Lung Cancer – Product Status 138
Table 288: Diagnostic Assay – Lung Cancer – Product Description 138
Table 289: MetaStat Inc Pipeline Products & Ongoing Clinical Trials Overview 139
Table 290: MenaCalc Lung – Product Status 139
Table 291: MenaCalc Lung – Product Description 139
Table 292: Milagen Inc Pipeline Products & Ongoing Clinical Trials Overview 140
Table 293: Immunoassay – Lung Cancer – Product Status 140
Table 294: Immunoassay – Lung Cancer – Product Description 140
Table 295: Myriad International GmbH Pipeline Products & Ongoing Clinical Trials Overview 141
Table 296: Diagnostic Assay – Lung Cancer – Product Status 141
Table 297: Diagnostic Assay – Lung Cancer – Product Description 141
Table 298: Nagoya University Pipeline Products & Ongoing Clinical Trials Overview 142
Table 299: Biomarker Assay – Lung Cancer – Product Status 142
Table 300: Biomarker Assay – Lung Cancer – Product Description 142
Table 301: Nanocytomics LLC Pipeline Products & Ongoing Clinical Trials Overview 143
Table 302: Cancer Risk Stratification Test – Lung Cancer – Product Status 143
Table 303: Cancer Risk Stratification Test – Lung Cancer – Product Description 143
Table 304: Nanostics Inc Pipeline Products & Ongoing Clinical Trials Overview 144
Table 305: ClarityDX Lung – Product Status 144
Table 306: ClarityDX Lung – Product Description 144
Table 307: NEOMICS Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 145
Table 308: AIMP2-DX2 Lung Cancer q-PCR Companion Diagnostic Test – Product Status 145
Table 309: AIMP2-DX2 Lung Cancer q-PCR Companion Diagnostic Test – Product Description 145
Table 310: NovaGray Pipeline Products & Ongoing Clinical Trials Overview 146
Table 311: NovaGray Lung Test – Product Status 146
Table 312: NovaGray Lung Test – Product Description 146
Table 313: Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 147
Table 314: NBT Diagnostic Test – Lung Cancer – Product Status 147
Table 315: NBT Diagnostic Test – Lung Cancer – Product Description 147
Table 316: Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview 148
Table 317: EarlyCDT – Lung Test – Product Status 148
Table 318: EarlyCDT – Lung Test – Product Description 148
Table 319: Oncimmune (USA) LLC – Ongoing Clinical Trials Overview 149
Table 320: EarlyCDT – Lung Test – Multi-center Case-control Study on Early Lung Cancer Detection using EarlyCDT-lung in China 150
Table 321: OncoCyte Corp Pipeline Products & Ongoing Clinical Trials Overview 151
Table 322: DetermaDx – Product Status 151
Table 323: DetermaDx – Product Description 151
Table 324: Lung Screening Assay – Product Status 152
Table 325: Lung Screening Assay – Product Description 152
Table 326: Next-Generation DetermaVu – Product Status 152
Table 327: Next-Generation DetermaVu – Product Description 153
Table 328: PanC-Dx – Lung Cancer – Product Status 153
Table 329: PanC-Dx – Lung Cancer – Product Description 153
Table 330: Oncolome Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 154
Table 331: Lung Cancer Personalized Medicine Test – Product Status 154
Table 332: Lung Cancer Personalized Medicine Test – Product Description 154
Table 333: Onconome, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 155
Table 334: Early Stage Lung Cancer Detection test – Product Status 155
Table 335: Early Stage Lung Cancer Detection test – Product Description 155
Table 336: OncoStem Diagnostics Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 156
Table 337: CanAssist – Lung Cancer – Product Status 156
Table 338: CanAssist – Lung Cancer – Product Description 156
Table 339: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 157
Table 340: Diagnostic Test – Non-Small Cell Lung Cancer – Product Status 157
Table 341: Diagnostic Test – Non-Small Cell Lung Cancer – Product Description 157
Table 342: Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 158
Table 343: Diagnostic Test – Lung Cancer – Product Status 158
Table 344: Diagnostic Test – Lung Cancer – Product Description 158
Table 345: OTraces Inc Pipeline Products & Ongoing Clinical Trials Overview 159
Table 346: LG Sera Dx – Product Status 159
Table 347: LG Sera Dx – Product Description 159
Table 348: Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview 160
Table 349: SaliMark LC – Product Status 160
Table 350: SaliMark LC – Product Description 160
Table 351: Peri Rx Inc – Ongoing Clinical Trials Overview 161
Table 352: SaliMark LC – Prospective Blinded Evaluation of Salivary Transcriptome Biomarkers for Non-small Cell Lung Cancer Detection 162
Table 353: PleX Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 163
Table 354: Diagnostic Assay – Lung Cancer – Product Status 163
Table 355: Diagnostic Assay – Lung Cancer – Product Description 163
Table 356: PreMD Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 164
Table 357: LungAlert – Product Status 164
Table 358: LungAlert – Product Description 164
Table 359: Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 165
Table 360: Biomarker Diagnostic Test – Lung Cancer – Product Status 165
Table 361: Biomarker Diagnostic Test – Lung Cancer – Product Description 165
Table 362: Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 166
Table 363: Biomarker Panel – Lung Cancer – Product Status 166
Table 364: Biomarker Panel – Lung Cancer – Product Description 166
Table 365: Proteomika (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 167
Table 366: Blood-Based Diagnostic Test – Lung Cancer – Product Status 167
Table 367: Blood-Based Diagnostic Test – Lung Cancer – Product Description 167
Table 368: Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 168
Table 369: Simoa HD-1 Analyzer – Lung Cancer – Product Status 168
Table 370: Simoa HD-1 Analyzer – Lung Cancer – Product Description 168
Table 371: Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 170
Table 372: Blood Test – Lung Cancer – Product Status 170
Table 373: Blood Test – Lung Cancer – Product Description 170
Table 374: Research Center Borstel Pipeline Products & Ongoing Clinical Trials Overview 171
Table 375: Diagnostic Kit – Lung Adenocarcinoma – Product Status 171
Table 376: Diagnostic Kit – Lung Adenocarcinoma – Product Description 171
Table 377: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 172
Table 378: Integrated Modular Analytics – Cyfra21-1/NSE Test – Product Status 172
Table 379: Integrated Modular Analytics – Cyfra21-1/NSE Test – Product Description 172
Table 380: Integrated Modular Analytics System – NSE Test – Product Status 173
Table 381: Integrated Modular Analytics System – NSE Test – Product Description 173
Table 382: MUC1 Expression Companion Diagnostic Test – Product Status 173
Table 383: MUC1 Expression Companion Diagnostic Test – Product Description 174
Table 384: Rosetta Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview 175
Table 385: ROS1 Lung Cancer Biomarker Assay – Product Status 175
Table 386: ROS1 Lung Cancer Biomarker Assay – Product Description 175
Table 387: Roswell Park Cancer Institute Pipeline Products & Ongoing Clinical Trials Overview 176
Table 388: Blood-Based Diagnostic Test – Lung Cancer – Product Status 176
Table 389: Blood-Based Diagnostic Test – Lung Cancer – Product Description 176
Table 390: Savicell Diagnostic Ltd. Pipeline Products & Ongoing Clinical Trials Overview 177
Table 391: Screening Test – Lung Cancer – Product Status 177
Table 392: Screening Test – Lung Cancer – Product Description 177
Table 393: Sengenics Corp Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 178
Table 394: Diagnostic Assay – NSCLC – Product Status 178
Table 395: Diagnostic Assay – NSCLC – Product Description 178
Table 396: Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 179
Table 397: CL-2000i – ProGRP Test – Product Status 179
Table 398: CL-2000i – ProGRP Test – Product Description 180
Table 399: Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 181
Table 400: ADVIA Centaur CP Immunoassay System – NSE – Product Status 181
Table 401: ADVIA Centaur CP Immunoassay System – NSE – Product Description 181
Table 402: ADVIA Centaur XP Immunoassay System – NSE – Product Status 182
Table 403: ADVIA Centaur XP Immunoassay System – NSE – Product Description 182
Table 404: ADVIA Centaur XPT Immunoassay System – NSE – Product Status 182
Table 405: ADVIA Centaur XPT Immunoassay System – NSE – Product Description 183
Table 406: Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 184
Table 407: Sienna Test – Lung Cancer – Product Status 184
Table 408: Sienna Test – Lung Cancer – Product Description 184
Table 409: Simon Fraser University Pipeline Products & Ongoing Clinical Trials Overview 185
Table 410: DORS Based Diagnostic Device – Non-small Cell Lung Cancer – Product Status 185
Table 411: DORS Based Diagnostic Device – Non-small Cell Lung Cancer – Product Description 185
Table 412: SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 186
Table 413: SomaSignal Test – Lung Cancer – Product Status 186
Table 414: SomaSignal Test – Lung Cancer – Product Description 186
Table 415: Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview 187
Table 416: Diagnostic Test – Lung Cancer – Product Status 187
Table 417: Diagnostic Test – Lung Cancer – Product Description 187
Table 418: Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 188
Table 419: Immunochemistry Test – CK19F – Product Status 188
Table 420: Immunochemistry Test – CK19F – Product Description 188
Table 421: Taizhou ZECEN Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 189
Table 422: CYFRA21-1 Detection Kit – Product Status 189
Table 423: CYFRA21-1 Detection Kit – Product Description 189
Table 424: The Prince Charles Hospital Pipeline Products & Ongoing Clinical Trials Overview 190
Table 425: Diagnostic Test – Lung Cancer – Product Status 190
Table 426: Diagnostic Test – Lung Cancer – Product Description 190
Table 427: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 191
Table 428: Oncomine Dx Target Test – BLU-667 – Product Status 191
Table 429: Oncomine Dx Target Test – BLU-667 – Product Description 191
Table 430: Transgene SA Pipeline Products & Ongoing Clinical Trials Overview 192
Table 431: aNK Test – Product Status 192
Table 432: aNK Test – Product Description 192
Table 433: Treos Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 193
Table 434: PolyPEPI 821 CDx – Product Status 193
Table 435: PolyPEPI 821 CDx – Product Description 193
Table 436: Universal Diagnostics SL Pipeline Products & Ongoing Clinical Trials Overview 194
Table 437: Blood-Based Diagnostic Test – Lung Cancer – Product Status 194
Table 438: Blood-Based Diagnostic Test – Lung Cancer – Product Description 194
Table 439: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 195
Table 440: Companion Diagnostic Test – Lung Cancer – Product Status 195
Contd..
